Main Navigation

Mercia
  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us

Audience

|

Change

  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub
  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub

Announcements

X-ray firm aims to improve breast cancer detection
The algae that could clean up our rivers and seas
Graeme Hall: Re-aligning your sales resource post-COVID-19
Coming Out: COVID-19 exit scenarios
The length, breadth and depth of COVID-19 and the economy
Mercia invests £11m during lockdown
Medherant partners with Cycle Pharmaceuticals
Mercia EIS Fund risk mitigation and COVID-19
HR software company closes second funding round
£2m for automation firm defining the future of work
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • Next
Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept

© 2026 Mercia Asset Management

  • Contact us
  • Privacy policy
  • Terms and conditions
  • Modern Slavery Statement
  • Diversity, Equity & Inclusion Policy
  • Sustainability

Mercia Asset Management PLC is registered in England and Wales: 09223445. Its subsidiaries, Mercia Fund Management Limited, Mercia Regional Ventures Limited, Mercia Business Loans Limited and Frontier Development Capital Limited are authorised and regulated by the Financial Conduct Authority.

Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept